Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

Background: Approximately 826,000 children, mostly young infants, die annually from invasive pneumococcal disease. A 6-10-14-week schedule of pneumococcal conjugate vaccine (PCV) is efficacious but neonatal PCV may provide earlier protection and better coverage. We conducted an open randomized contr...

Full description

Bibliographic Details
Main Authors: Pomat, William, van den Biggelaar, Anita, Phuanukoonnon, Suparat, Francis, Jacinta, Jacoby, Peter, Siba, Peter, Alpers, Michael, Reeder, John, Holt, Patrick, Richmond, Peter, Lehmann, Deborah
Format: Journal Article
Published: PLOS 2013
Online Access:http://hdl.handle.net/20.500.11937/7331

Internet

http://hdl.handle.net/20.500.11937/7331

Similar Items